340 related articles for article (PubMed ID: 31354427)
1. Gut Microbiota Differs Between Parkinson's Disease Patients and Healthy Controls in Northeast China.
Li C; Cui L; Yang Y; Miao J; Zhao X; Zhang J; Cui G; Zhang Y
Front Mol Neurosci; 2019; 12():171. PubMed ID: 31354427
[No Abstract] [Full Text] [Related]
2. Gut Microbiota Composition in Patients with Neurodegenerative Disorders (Parkinson's and Alzheimer's) and Healthy Controls: A Systematic Review.
Heravi FS; Naseri K; Hu H
Nutrients; 2023 Oct; 15(20):. PubMed ID: 37892440
[TBL] [Abstract][Full Text] [Related]
3. [Features of gut microbiota in patients with idiopathic Parkinson's disease].
Li Y; Li RX; Du YT; Xu XJ; Xue Y; Gao D; Gao T; Sheng Z; Zhang LY; Tuo HZ
Zhonghua Yi Xue Za Zhi; 2020 Apr; 100(13):1017-1022. PubMed ID: 32294860
[No Abstract] [Full Text] [Related]
4. Intrauterine Hypoxia Changed the Colonization of the Gut Microbiota in Newborn Rats.
Sun Y; Li L; Song J; Mao W; Xiao K; Jiang C
Front Pediatr; 2021; 9():675022. PubMed ID: 33981656
[No Abstract] [Full Text] [Related]
5. Altered gut microbiota in patients with idiopathic Parkinson's disease: an age-sex matched case-control study.
Babacan Yildiz G; Kayacan ZC; Karacan I; Sumbul B; Elibol B; Gelisin O; Akgul O
Acta Neurol Belg; 2023 Jun; 123(3):999-1009. PubMed ID: 36719617
[TBL] [Abstract][Full Text] [Related]
6. An analysis of the characteristics of the intestinal flora in patients with Parkinson's disease complicated with constipation.
Chen W; Bi Z; Zhu Q; Gao H; Fan Y; Zhang C; Liu X; Ye M
Am J Transl Res; 2021; 13(12):13710-13722. PubMed ID: 35035709
[TBL] [Abstract][Full Text] [Related]
7. Altered gut microbiota in Parkinson's disease patients/healthy spouses and its association with clinical features.
Zhang F; Yue L; Fang X; Wang G; Li C; Sun X; Jia X; Yang J; Song J; Zhang Y; Guo C; Ma G; Sang M; Chen F; Wang P
Parkinsonism Relat Disord; 2020 Dec; 81():84-88. PubMed ID: 33099131
[TBL] [Abstract][Full Text] [Related]
8. Parkinson's disease and Parkinson's disease medications have distinct signatures of the gut microbiome.
Hill-Burns EM; Debelius JW; Morton JT; Wissemann WT; Lewis MR; Wallen ZD; Peddada SD; Factor SA; Molho E; Zabetian CP; Knight R; Payami H
Mov Disord; 2017 May; 32(5):739-749. PubMed ID: 28195358
[TBL] [Abstract][Full Text] [Related]
9. Gut microbiota in patients with Parkinson's disease in southern China.
Lin A; Zheng W; He Y; Tang W; Wei X; He R; Huang W; Su Y; Huang Y; Zhou H; Xie H
Parkinsonism Relat Disord; 2018 Aug; 53():82-88. PubMed ID: 29776865
[TBL] [Abstract][Full Text] [Related]
10. Influence of aerobic exercise training on mice gut microbiota in Parkinson's disease.
Fan T; Li X; Zhang X; Zhang J; Sun L; Chen J; Fu C
Turk J Biol; 2022; 46(4):288-297. PubMed ID: 37529095
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of the Relationship Between Akkermansia Genomic Diversity in Gut Microbiota and Parkinson's Disease Dementia].
Arıkan M; Kahraman Demir T; Yıldız Z; Helvacı Yılmaz N; Şen A; Hanoğlu L; Yıldırım S
Mikrobiyol Bul; 2024 Jan; 58(1):13-28. PubMed ID: 38263937
[TBL] [Abstract][Full Text] [Related]
12. Dysbiosis of the Beneficial Gut Bacteria in Patients with Parkinson's Disease from India.
Pavan S; Gorthi SP; Prabhu AN; Das B; Mutreja A; Vasudevan K; Shetty V; Ramamurthy T; Ballal M
Ann Indian Acad Neurol; 2023; 26(6):908-916. PubMed ID: 38229613
[TBL] [Abstract][Full Text] [Related]
13. Altered gut microbiota and inflammatory cytokine responses in patients with Parkinson's disease.
Lin CH; Chen CC; Chiang HL; Liou JM; Chang CM; Lu TP; Chuang EY; Tai YC; Cheng C; Lin HY; Wu MS
J Neuroinflammation; 2019 Jun; 16(1):129. PubMed ID: 31248424
[TBL] [Abstract][Full Text] [Related]
14. Altered gut microbiota in Parkinson's disease patients with motor complications.
Takahashi K; Nishiwaki H; Ito M; Iwaoka K; Takahashi K; Suzuki Y; Taguchi K; Yamahara K; Tsuboi Y; Kashihara K; Hirayama M; Ohno K; Maeda T
Parkinsonism Relat Disord; 2022 Feb; 95():11-17. PubMed ID: 34954497
[TBL] [Abstract][Full Text] [Related]
15. Associations between gut microbiota characteristics and non-motor symptoms following pharmacological and surgical treatments in Parkinson's disease patients.
Gorecka-Mazur A; Krygowska-Wajs A; Furgala A; Li J; Misselwitz B; Pietraszko W; Kwinta B; Yilmaz B
Neurogastroenterol Motil; 2024 Jun; ():e14846. PubMed ID: 38873926
[TBL] [Abstract][Full Text] [Related]
16. Short-Chain Fatty Acid-Producing Gut Microbiota Is Decreased in Parkinson's Disease but Not in Rapid-Eye-Movement Sleep Behavior Disorder.
Nishiwaki H; Hamaguchi T; Ito M; Ishida T; Maeda T; Kashihara K; Tsuboi Y; Ueyama J; Shimamura T; Mori H; Kurokawa K; Katsuno M; Hirayama M; Ohno K
mSystems; 2020 Dec; 5(6):. PubMed ID: 33293403
[TBL] [Abstract][Full Text] [Related]
17. Alterations of gut microbiota and metabolome with Parkinson's disease.
Yan Z; Yang F; Cao J; Ding W; Yan S; Shi W; Wen S; Yao L
Microb Pathog; 2021 Nov; 160():105187. PubMed ID: 34530073
[TBL] [Abstract][Full Text] [Related]
18. The nasal and gut microbiome in Parkinson's disease and idiopathic rapid eye movement sleep behavior disorder.
Heintz-Buschart A; Pandey U; Wicke T; Sixel-Döring F; Janzen A; Sittig-Wiegand E; Trenkwalder C; Oertel WH; Mollenhauer B; Wilmes P
Mov Disord; 2018 Jan; 33(1):88-98. PubMed ID: 28843021
[TBL] [Abstract][Full Text] [Related]
19. Oral, Nasal, and Gut Microbiota in Parkinson's Disease.
Li Z; Lu G; Luo E; Wu B; Li Z; Guo J; Xia Z; Zheng C; Su Q; Zeng Y; Chan WY; Su X; Qiu X; Zheng X; Cai Q; Xu Y; Chen Y; Fan Y; Chen W; Yu Z; Chen X; Zheng C; Wang M; Poon WS; Luo X
Neuroscience; 2022 Jan; 480():65-78. PubMed ID: 34695538
[TBL] [Abstract][Full Text] [Related]
20. A Pilot Microbiota Study in Parkinson's Disease Patients versus Control Subjects, and Effects of FTY720 and FTY720-Mitoxy Therapies in Parkinsonian and Multiple System Atrophy Mouse Models.
Vidal-Martinez G; Chin B; Camarillo C; Herrera GV; Yang B; Sarosiek I; Perez RG
J Parkinsons Dis; 2020; 10(1):185-192. PubMed ID: 31561385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
